Aesculap to Distribute Misonix BoneScalpel
An example of the precision afforded by Misonix ultrasound cutting technologies: an eggshell is cut and the membrane is left intact. In an agreement finalized […]
News
Revenue Guidance Revised as ATS Medical Seeks to Placate the FDA
Last week, word came from the FDA that ATS Medical would need to provide additional information and clarification to support its PMA for the ATS […]
Should Hospital Emergency Rooms Adopt the Managerial Techniques Found at Starbucks?
According to researchers at the Cambridge Health Alliance and Harvard Medical School, the median wait time in hospital emergency rooms increased 36% from 1997 to […]
HemeScan: CombiMatrix and Clarient to Advance Personalized Therapies for Chronic Lymphotic Leukemia
More partnering news, this time from CombiMatrix and Clarient, who will market and sell a genomics-based cancer test called HemeScan. HemeScan was developed by CombiMatrix; […]
Blue Shield of California Sees the 308-nanometer Light
Blue Shield of California, a plan that covers more than three million people, has approved payment for mild to moderate psoriasis treatment using the PhotoMedex […]
A Filtration Collaboration: Delcath and Aethlon to Expand Cancer Treatment Options
Aethlon Medical and Delcath Systems have agreed to jointly research and develop a new filtration cartridge for use in Delcath’s percutaneous hepatic perfusion (“PHP”) system. […]
BioSphere to Market Microspheres in China
Company eyes large opportunity in treating liver cancer Rockland, MA-based BioSphere Medical reported this week that the Medical Device Department of the People’s Republic of […]
[Video Profile] Interview with John Seaberg, CEO of NeoChord
This interview with John Seaberg, CEO of NeoChord, is the first of many filmed earlier this month at the OMP Finance Forum. NeoChord aims to […]
Bad Tasting Medicine a Thing of the Past?
While some might consider forcing down terrible-tasting cough syrup a right of passage, this childhood trauma may soon go the way of chicken pox. Aversive […]